U.S. FDA Designates Mallinckrodt's StrataGraft® as Regenerative Medicine Advanced Therapy
Go back to U.S. FDA Designates Mallinckrodt's StrataGraft® as Regenerative Medicine Advanced Therapy| Medtronic Inc. (NYSE: MDT) | Delayed: 80.63 +1.36 (1.72%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $79.27 | 52 Week High | $89.27 | |||
| Open | $79.75 | 52 Week Low | $71.03 | |||
| Day High | $80.75 | P/E | 22.91 | |||
| Day Low | $79.58 | EPS | $3.52 | |||
| Volume | 8,482,506 | |||||
| MALLINCKRODT PUBLIC LIMITED COMPANY (NYSE: MNK) | Delayed: 0.34 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.34 | 52 Week High | $85.83 | |||
| Open | $30.62 | 52 Week Low | $50.90 | |||
| Day High | $0.34 | P/E | 0.34 | |||
| Day Low | $0.34 | EPS | $1.00 | |||
| Volume | 84 | |||||
